|
|
Beating Cancer with Nutrition, book with CD $14.95 Beating Cancer with Nutrition. Sugar feeds Cancer: diet and supplements can starve tumors· Nutrition makes chemo and radiation more toxic to the tumor while protecting the patient. Nutrition changes underlying causes of cancer, improving outcome for cancer patients regardless of other therapies. Why Beating Cancer with Nutrition is unique: The book was developed after working with over 500 cancer… |
|
|
Knockout: Interviews with Doctors Who Are Curing Cancer–And How to Prevent Getting It in the First Place $9.79 In Knockout, Suzanne Somers interviews doctors who are successfully using the most innovative cancer treatments—treatments that build up the body rather than tear it down. Somers herself has stared cancer in the face, and a decade later she has conquered her fear and has emerged confident with the path she’s chosen.Now she shares her personal choices and outlines an array of options from doctors… |
|
|
What Your Doctor May Not Tell You About(TM): Premenopause: Balance Your Hormones and Your Life from Thirty to Fifty $4.04 I’m too Young for Menopause-So Why Do I Feel Like this? You could be experiencing unexplained weight gain…fatigue…mood swings…loss of libido…fibroids…tender or lumpy breasts…endometriosis…PMS…infertility…memory loss…migraines…very heavy or light periods…cold hands and feet…or a combination of these symptoms. You may have been told they’re “nothing,” or stress, or even men… |
|
|
After Breast Cancer (Paperback) $10.77 The post-treatment phase can be a perplexing one for cancer survivors, but here an experienced oncology social worker provides supportive and very practical advice for dealing with the many physical, emotional, and social challenges. Author Hester Hill… |
|
|
At-A-Glance QuickNotes Breast Cancer Appointment Book $22.99 1 1 Day per 2 Page 1 Each 1 Week per 2 Page 12 Month 13.28 oz 30% 76PN0105 8.50″ x 10.50″ 8:00 AM to 5:00 PM – Hourly QuickNotes Special Edition Appointment Book allows you to support breast cancer research with your weekly/monthly planning needs. A portion of the proceeds are donated to the nonprofit City of Hope to support breast cancer research, treatment and education. Spread awareness with the pink ribbon symbol on the cover and beside the calendar reference at the top. Planning pages range 12 months from January to December. Two-page-per-week spreads offer hourly appointment times from 8 AM to 5 PM even on weekends, Julian dates, and past, current and three future months reference. Monthly pages have a full month on left page, QuickNotes area on right page, and two past and six future months reference. Appointment book includes a storage pocket and simulated leather cover. Pages are printed in four colors on quality recycled paper made with 30 percent post-consumer material. Appointment Book At-A-Glance Black December January Julian Leather Cover MeadWestvaco Monthly No Paper Pocket QuickNotes QuickNotes Breast Cancer Appointment Book Weekly Yes www.meadwestvaco.com |
|
|
The Complete Natural Medicine Guide to Breast Cancer $6.99 A naturopathic approach to breast cancer, concentrating on nutrition, risk factors, exercise and lifestyle changes that can prevent or help in the treatment of breast cancer. |
|
|
Baumgartens Breast Cancer Lanyard $5.99 0.63″ Width x 36″ Length 1 97500 Breast Cancer Awareness Lanyard shows your support for finding a cure for this deadly disease or inspiring others. Use included hook to attach lanyard to ID badges, keys or anything you need to access quickly. Lanyard is made of nylon. Baumgartens Breast Cancer Lanyard Lanyard www.b3.net |
|
|
After Breast Cancer $5.99 As women with breast cancer quickly discover, the completion of their treatment does not mean that life will continue much as it had been before their diagnosis. Rather than feeling relief, they are often exhausted, anxious, and fearful. Hungry for a return to a “normal” life, they discover that the old version of normal no longer applies. They are beset by physical discomforts and are emotionally volatile, fearful of intimacy, afraid for their children, and worried about recurrence. There could be no more knowledgeable a guide for women embarking on this new journey than After Breast Cancer – written not only with professional wisdom by an oncology social worker but also from the author’s own experience as a breast cancer survivor. It is a practical, empathetic, comprehensive handbook on the full range of issues – physical, psychological, medical, logistical, human – that women face as they learn to reshape their lives as survivors; and it will enable them to rediscover their future. |
|
|
Paper Mate Dryline Grip Breast Cancer Correction Film $2.99 0% 0.20″ 0.48 oz 1 1 Each 1742839 27.83 ft Dryline Grip Correction Film supports breast cancer awareness. Paper Mate will donate 20 cents with each purchase to the nonprofit City of Hope for breast cancer research, treatment and education. Super strong tear proof film resists breaking, and applies dry for instant corrections. Unique shape and grip provide comfort and control. Great for correcting single line of text before copying or faxing. Break-resistant DryLine Grip Dryline Grip Breast Cancer Correction Film Ergonomic (Included) No Non-refillable Paper Mate Pink Dispenser Sanford, L.P. Tear Resistant – Film Typewriter Correction Film White Yes www.sanford.com |
|
|
Angiotensin-(1-7): A novel small molecule for the targeted treatment of triple negative breast cancer. $49.99 Triple negative breast cancer (TNBC), an aggressive breast tumor that disproportionately affects young and minority women, is associated with a poor survival rate regardless of stage at diagnosis due to development of distant metastases. Tumors from women with TNBC lack estrogen receptors and progesterone receptors and have basal expression of the human epidermal growth factor receptor 2 (HER2), severely limiting therapeutic strategies. The purpose of this study was to determine whether angiotensin-(1-7) [Ang-(1-7)], an endogenous peptide hormone that activates the AT(1-7) receptor mas , inhibits the growth of triple negative breast cancer cells and tumors and identify the molecular mechanisms for the inhibition of cancer cell growth. Injection of MDA-MB-231 cells into the mammary fat pad of athymic mice resulted in triple negative breast tumors that were treated for 28 days with either saline or Ang-(1-7). The average tumor volume from mice treated with the heptapeptide was approximately 3-fold less than the size of tumors from control animals (170.8 +/- 21.4 mm3 vs. 546.7 +/- 87.9 mm3; n = 5, p < 0.05) and tumor weight was reduced from 1.0 +/- 0.2 g in the saline-treated mice to 0.5 +/- 0.1 g in Ang-(1-7)-treated mice (n = 5, p < 0.05). The reduced size of Ang-(1-7)-treated tumors was associated with low immunoreactivity to Ki67, a proliferation marker (84.2 +/- 8.2 compared to 41 +/- 7.6), suggesting that Ang-(1-7) attenuates cell growth. Activity of the MAP kinases ERK1 and ERK2 was reduced in tumors of Ang-(1-7)-treated mice which was associated with a receptor-mediated increase in the MAP kinase phosphatase DUSP1 (1.01 +/- 0.1 relative gene expression in tumors from saline-treated mice compared to 1.78 +/- 0.13 in tumors from Ang-(1-7)-treated mice). The decrease in tumor growth of Ang-(1-7)-treated mice was also associated with a reduction in the endothelial cell marker CD34 (a decrease in vessel density from 87.8 +/- 6.4 in tumors from saline-treated |
|
|
Angiotensin-(1-7): A novel small molecule for the targeted treatment of triple negative breast cancer. $49.99 Triple negative breast cancer (TNBC), an aggressive breast tumor that disproportionately affects young and minority women, is associated with a poor survival rate regardless of stage at diagnosis due to development of distant metastases. Tumors from women with TNBC lack estrogen receptors and progesterone receptors and have basal expression of the human epidermal growth factor receptor 2 (HER2), severely limiting therapeutic strategies. The purpose of this study was to determine whether angiotensin-(1-7) [Ang-(1-7)], an endogenous peptide hormone that activates the AT(1-7) receptor mas , inhibits the growth of triple negative breast cancer cells and tumors and identify the molecular mechanisms for the inhibition of cancer cell growth. Injection of MDA-MB-231 cells into the mammary fat pad of athymic mice resulted in triple negative breast tumors that were treated for 28 days with either saline or Ang-(1-7). The average tumor volume from mice treated with the heptapeptide was approximately 3-fold less than the size of tumors from control animals (170.8 +/- 21.4 mm3 vs. 546.7 +/- 87.9 mm3; n = 5, p < 0.05) and tumor weight was reduced from 1.0 +/- 0.2 g in the saline-treated mice to 0.5 +/- 0.1 g in Ang-(1-7)-treated mice (n = 5, p < 0.05). The reduced size of Ang-(1-7)-treated tumors was associated with low immunoreactivity to Ki67, a proliferation marker (84.2 +/- 8.2 compared to 41 +/- 7.6), suggesting that Ang-(1-7) attenuates cell growth. Activity of the MAP kinases ERK1 and ERK2 was reduced in tumors of Ang-(1-7)-treated mice which was associated with a receptor-mediated increase in the MAP kinase phosphatase DUSP1 (1.01 +/- 0.1 relative gene expression in tumors from saline-treated mice compared to 1.78 +/- 0.13 in tumors from Ang-(1-7)-treated mice). The decrease in tumor growth of Ang-(1-7)-treated mice was also associated with a reduction in the endothelial cell marker CD34 (a decrease in vessel density from 87.8 +/- 6.4 in tumors from saline-treated |
|
|
Integrated Cancer Management: Surgery, Medical Oncology, and Radiation Oncology $152.05 This definitive, up-to-the-minute reference explores the range of metabolic, nutritional, immunologic, and psychological changes that can occur while treating local, regional, and distant cancer, and examines the influence of these factors on outcomes and recovery. Includes clearly written, concise summaries of oncological therapy emphasizing critical decision making in patient management! Written by surgeons, medical oncologists, and radiation therapists with recognized expertise in cancer therapy, Integrated Cancer Management compares and contrasts treatment alternatives based on tumor stage and biology analyzes clinical prognostic factors, treatment indications, toxicity, and tumor response addresses the use of endoscopy, magnetic resonance imaging (MRI), and computed tomography (CT) to detect and diagnose tumors reviews the state-of-the-art treatment of breast, gastric, thoracic, and colorectal cancer outlines the clinical management of pancreatic and periampullary cancers, hepatic and biliary tumors, and endocrine tumors summarizes the treatment of melanoma and soft-tissue sarcoma reviews oncologic emergencies and the role of nutrition in treating cancer discusses various surgical procedures and their roles in the treatment of primary, regional, and metastatic tumor sites assesses the benefits of pre- and postoperative external-beam radiotherapy and brachytherapy identifies chemotherapy for use in the adjuvant, therapeutic, and neoadjuvant setting presents the current concepts and potential role of molecular biologic techniques in the diagnosis and treatment of cancer and more! Containing over 1,000 references to urge continued study, Integrated Cancer Management is designed forsurgical, radiation, and medical oncologists; radiologists and radiation therapists; hematologists; immunologists; nephrologists; urologists; gastroenterologists; pathologists; internists; gerontologists; primary care physicians; and medical school students in these disciplines. |